Figure 1. The left medial clavicular area appeared swollen.
Figure 2. A technetium Tc 99m bone scan showed multiple areas of increased uptake in the ribs, thoracic and lumbar spine, left knee, left clavicle, right ankle, and right shoulder.
Figure 3. Computed tomography of the chest revealed anterior mediastinal, bilateral hilar, and azygoesophageal lymphadenopathy as well as thickened interstitial markings and patchy ground glass opacity of the lung fields.
Additional laboratory examination results included a white blood cell count of 11.8 × 109/L with a differential count of 55% band forms; hemoglobin, 105 g/L; hypercalcuria, 260 mg/24 h; and an elevated angiotensin-converting enzyme level, 94 U/L. A bone marrow aspirate showed noncaseating granulomas on routine staining. Pulmonary function testing revealed moderately severe restrictive lung disease with a diffusion impairment.
Sarcoidosis, a multisystem disease of unknown cause, has a peak incidence between ages 20 and 40 years, but it is not rare in adolescents. Kendig1 observed 2 age peaks, 1 in adolescence and 1 in young adulthood. Regional and ethnic variations in incidence are marked; the incidence ranges from 30 to 640 per 100,000 population, with the highest incidence in the southeastern rural United States, particularly among African Americans.2
The diagnosis of sarcoidosis is most commonly made when chest radiography, obtained for unrelated reasons or pulmonary symptoms, unexpectedly reveals hilar adenopathy. Patients in the pediatric age group are more likely than adults to have multiple symptoms, signs, and abnormalities on laboratory studies, including cough (50%), fatigue (50%), bone and joint pain (45%), parotid enlargement (40%), fever (40%), hypercalcuria (80%), hypergammaglobulinemia (90%), and restrictive impairment on pulmonary function testing (50%).3 Elevated serum levels of angiotensin-converting enzyme have been reported in 80% of children with sarcoidosis.4 Noncaseating granulomas found in affected tissues are the hallmark of sarcoidosis but are not specific for the disease.
Musculoskeletal symptoms are common in sarcoidosis, but bone involvement detected on radiography is reported to be uncommon, affecting 1% to 13% of patients.5 The bones of the hands and feet are the most common sites of detected abnormalities.5 Bone involvement is reported to portend a worse prognosis, with a mortality rate 4 times higher in patients who are detected to have abnormalities on bone radiography than in those with normal findings.4 Almost half of patients have no signs or symptoms related to bone involvement despite the abnormal radiographic findings.4 Of patients with symptomatic osseous sarcoidosis, the most common site of involvement is the vertebrae, and the duration of illness before the onset of musculoskeletal symptoms is a year or less.6
Bone involvement is much more commonly detected with the use of bone scans than with routine radiography.7- 10 Most patients with abnormalities detected by bone scan have related symptoms. Bone scans may also detect muscle involvement of sarcoidosis.11 Magnetic resonance imaging may be even more sensitive in detecting bone involvement. Three children with fever of unknown origin and leg pain who had normal findings on bone radiography and bone scans were found to have multifocal nodular lesions in their tibiae on magnetic resonance imaging.12 Bone involvement in sarcoidosis may be more common than previously reported, particularly in patients with musculoskeletal symptoms. Bone scans and magnetic resonance imaging may increase the likelihood of detecting bony abnormalities.
Accepted for publication February 4, 2000.
Reprints: Christine Stahl, MD, Division of Adolescent Medicine, Cook County Hospital, 1900 W Polk St, Room 1112, Chicago, IL 60657.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA Pediatrics editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.